Page last updated: 2024-08-21

decabromobiphenyl ether and Diabetes Mellitus, Type 1

decabromobiphenyl ether has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gu, J; Qiu, LL; Sun, ZZ; Wang, SL; Wang, X; Wang, XC; Xiao, X; Xu, Q; Zhang, XH; Zhang, Z; Zhen, B; Zhou, S	1

Other Studies

1 other study(ies) available for decabromobiphenyl ether and Diabetes Mellitus, Type 1

Article	Year
Mechanism of BDE209-induced impaired glucose homeostasis based on gene microarray analysis of adult rat liver. Archives of toxicology, 2013, Volume: 87, Issue:8 Topics: Animals; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Halogenated Diphenyl Ethers; Homeostasis; Hyperglycemia; Lipid Metabolism; Liver; Male; Metabolic Networks and Pathways; Microarray Analysis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha	2013

Article

Year

Mechanism of BDE209-induced impaired glucose homeostasis based on gene microarray analysis of adult rat liver.

Archives of toxicology, 2013, Volume: 87, Issue:8

Topics: Animals; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Halogenated Diphenyl Ethers; Homeostasis; Hyperglycemia; Lipid Metabolism; Liver; Male; Metabolic Networks and Pathways; Microarray Analysis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha

2013